<ARTICLE> 5 <LEGEND> THE FINANCIAL STATEMENTS OF RIBOZYME PHARMACEUTICALS, INC. FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1999. </LEGEND> <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-1999 <PERIOD-START> JAN-01-1999 <PERIOD-END> SEP-30-1999 <CASH> 12,059,991 <SECURITIES> 2,910,076 <RECEIVABLES> 3,222,461 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 18,522,444 <PP&E> 12,033,609 <DEPRECIATION> 8,053,828 <TOTAL-ASSETS> 27,352,705 <CURRENT-LIABILITIES> 2,052,145 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 112,079 <OTHER-SE> 17,153,345 <TOTAL-LIABILITY-AND-EQUITY> 27,352,705 <SALES> 0 <TOTAL-REVENUES> 1,806,849 <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> 3,782,369 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 114,964 <INCOME-PRETAX> (2,565,172) <INCOME-TAX> 0 <INCOME-CONTINUING> (2,565,172) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (2,565,172) <EPS-BASIC> (0.23) <EPS-DILUTED> (0.23)